3 Result(s)
within
J.-M. Classe
Cancer Research
Drug Resistance
Molecular Medicine
-
Article
Open AccessAxillary lymph node micrometastases decrease triple-negative early breast cancer survival
Triple-negative breast cancers (TNBCs) are the most deadly form of breast cancer (BC) subtypes. Axillary lymph node involvement (ALNI) has been described to be prognostic in BC taken as a whole, but its progno...
-
Article
Open AccessPrognostic impact of syndecan-1 expression in invasive ductal breast carcinomas
Carcinoma cells lack syndecan-1 expression when they are transiting from an epithelial to a less-differentiated mesenchymal phenotype (epithelial–mesenchymal transition, EMT). Furthermore, a shift of syndecan-...
-
Article
Open AccessG388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis
This study screened large cohorts of node-positive and node-negative breast cancer patients to determine whether the G388R mutation of the FGFR4 gene is a useful prognostic marker for breast cancer as reported by...
